Evaluating the role of biomarkers for cardiovascular risk prediction: Focus on CRP, BNP and urinary microalbumin

Abigail Khan, Thomas J. Wang

Research output: Contribution to journalReview article

23 Citations (Scopus)

Abstract

Cardiovascular disease is a significant cause of morbidity and mortality, making cardiovascular prevention an important public health goal. The use of cardiac biomarkers represents a potential, noninvasive method to identify asymptomatic individuals who are most likely to develop cardiovascular disease. Several known biomarkers predict cardiovascular risk above and beyond conventional risk factors. Nonetheless, available evidence suggests that current biomarkers do not have sufficient sensitivity or specificity to justify widespread use for cardiovascular risk prediction. New developments in molecular biology and genetics may allow the identification of additional biomarkers, likely acting via different pathways, to achieve this goal.

Original languageEnglish (US)
Pages (from-to)793-804
Number of pages12
JournalExpert Review of Molecular Diagnostics
Volume7
Issue number6
DOIs
StatePublished - Nov 1 2007
Externally publishedYes

Fingerprint

Biomarkers
Molecular Biology
Cardiovascular Diseases
Public Health
Morbidity
Sensitivity and Specificity
Mortality

Keywords

  • B-type natriuretic peptide
  • Biomarker
  • C-reactive protein
  • Cardiovascular risk
  • Urinary microalbumin

ASJC Scopus subject areas

  • Genetics

Cite this

Evaluating the role of biomarkers for cardiovascular risk prediction : Focus on CRP, BNP and urinary microalbumin. / Khan, Abigail; Wang, Thomas J.

In: Expert Review of Molecular Diagnostics, Vol. 7, No. 6, 01.11.2007, p. 793-804.

Research output: Contribution to journalReview article

@article{e75f0dee7cf246b0939c39f37eabc9ef,
title = "Evaluating the role of biomarkers for cardiovascular risk prediction: Focus on CRP, BNP and urinary microalbumin",
abstract = "Cardiovascular disease is a significant cause of morbidity and mortality, making cardiovascular prevention an important public health goal. The use of cardiac biomarkers represents a potential, noninvasive method to identify asymptomatic individuals who are most likely to develop cardiovascular disease. Several known biomarkers predict cardiovascular risk above and beyond conventional risk factors. Nonetheless, available evidence suggests that current biomarkers do not have sufficient sensitivity or specificity to justify widespread use for cardiovascular risk prediction. New developments in molecular biology and genetics may allow the identification of additional biomarkers, likely acting via different pathways, to achieve this goal.",
keywords = "B-type natriuretic peptide, Biomarker, C-reactive protein, Cardiovascular risk, Urinary microalbumin",
author = "Abigail Khan and Wang, {Thomas J.}",
year = "2007",
month = "11",
day = "1",
doi = "10.1586/14737159.7.6.793",
language = "English (US)",
volume = "7",
pages = "793--804",
journal = "Expert Review of Molecular Diagnostics",
issn = "1473-7159",
publisher = "Expert Reviews Ltd.",
number = "6",

}

TY - JOUR

T1 - Evaluating the role of biomarkers for cardiovascular risk prediction

T2 - Focus on CRP, BNP and urinary microalbumin

AU - Khan, Abigail

AU - Wang, Thomas J.

PY - 2007/11/1

Y1 - 2007/11/1

N2 - Cardiovascular disease is a significant cause of morbidity and mortality, making cardiovascular prevention an important public health goal. The use of cardiac biomarkers represents a potential, noninvasive method to identify asymptomatic individuals who are most likely to develop cardiovascular disease. Several known biomarkers predict cardiovascular risk above and beyond conventional risk factors. Nonetheless, available evidence suggests that current biomarkers do not have sufficient sensitivity or specificity to justify widespread use for cardiovascular risk prediction. New developments in molecular biology and genetics may allow the identification of additional biomarkers, likely acting via different pathways, to achieve this goal.

AB - Cardiovascular disease is a significant cause of morbidity and mortality, making cardiovascular prevention an important public health goal. The use of cardiac biomarkers represents a potential, noninvasive method to identify asymptomatic individuals who are most likely to develop cardiovascular disease. Several known biomarkers predict cardiovascular risk above and beyond conventional risk factors. Nonetheless, available evidence suggests that current biomarkers do not have sufficient sensitivity or specificity to justify widespread use for cardiovascular risk prediction. New developments in molecular biology and genetics may allow the identification of additional biomarkers, likely acting via different pathways, to achieve this goal.

KW - B-type natriuretic peptide

KW - Biomarker

KW - C-reactive protein

KW - Cardiovascular risk

KW - Urinary microalbumin

UR - http://www.scopus.com/inward/record.url?scp=36448937142&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36448937142&partnerID=8YFLogxK

U2 - 10.1586/14737159.7.6.793

DO - 10.1586/14737159.7.6.793

M3 - Review article

C2 - 18020909

AN - SCOPUS:36448937142

VL - 7

SP - 793

EP - 804

JO - Expert Review of Molecular Diagnostics

JF - Expert Review of Molecular Diagnostics

SN - 1473-7159

IS - 6

ER -